Testicular desmoplastic small round cell tumor: a case report and review of literature by Gui-Ming Zhang et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Zhang et al. World Journal of Surgical Oncology 2014, 12:227
http://www.wjso.com/content/12/1/227CASE REPORT Open AccessTesticular desmoplastic small round cell tumor: a
case report and review of literature
Gui-Ming Zhang1,2†, Yao Zhu1†, Hua-Lei Gan3 and Ding-Wei Ye1*Abstract
Background: Desmoplastic small round cell tumor (DSRCT) is an uncommon and highly aggressive malignancy with
undetermined histogenesis and poor prognosis. To date, no case of testicular DSRCT has been reported in the literature.
Case: A 42-year-old Chinese man presented with painless swelling of his left testis and a painless palpable nodule in his
left inguinal region. Computed tomography showed a solid mass in the left testis and multiple metastases in the body.
Laboratory tests gave no abnormal results. Left radical orchiectomy was performed, and histopathological and molecular
pathological examination showed typical features of DSRCT. Six cycles of chemotherapy were administrated after the
operation, leading to partial remission. Postoperative 9-month follow-up indicated no progression.
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Desmoplastic small round cell tumor (DSRCT) is an
extremely rare malignancy with undetermined histogenic
origin. To date, about 300 cases have been reported in the
literature, since it was first described as a mesenchymal
entity with distinct clinicopathological features by Gerald
and Rosai in 1989 [1,2]. DSRCT is prone to develop in
adolescents and young adults, and the incidence in males
is more than three times that in females [3]. The majority
of DSRCTs originate from the abdominal cavity and pelvis,
thus the retroperitoneum, omentum, and mesentery are
often involved, in addition to multiple peritoneal tumors
[4]. Although rarer, invasion of extraperitoneal sites, such
as the central nervous system, nasal sinus, lung, bone
and soft tissues, kidney, ovary and paratesticular region,
has been documented [5-11]. However, no DSRCT derived
from testis has been reported to date. Herein, we report
a case of solid neoplasm in testis that was confirmed
pathologically to be testicular DSRCT.Case presentation
A 42-year-old Chinese man was admitted to the Depart-
ment of Urology at our hospital, with an 8-month history* Correspondence: dwyeli@163.com
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unless otherwise stated.of painless swelling of his left testis and a 6-month history
of a painless palpable nodule in his left inguinal region. He
had no relevant personal or family history of malignancy.
On physical examination, an egg-size solid lump was
found in the left testis, and a palpable, slightly mobile,
solid nodule, 2 × 3 cm in size, in the left inguinal region.
Laboratory tests, including α-fetoprotein, β-human cho-
rionic gonadotropin, and lactate dehydrogenase, gave
no abnormal results. Computed tomography (CT) showed
a confined solid mass, 2 × 3 cm in size with homogenous
attenuation in the left testis, and multiple lesions in the
right diaphragmatic crus, retroperitoneal region, and
peritoneal and pelvic cavity, in the left inguinal region, and
in the near-bilateral iliac vessels, suggestive of multiple
metastases (Figure 1). In addition, the patient’s left renal
pelvis and ureter were dilated.
The preoperative diagnosis was left testicular tumor
with multiple metastases. Left radical orchiectomy was
carried out, and the cut surface of the tumor showed
fish-like changes. Histopathological examination of the
resected specimen revealed a malignant tumor composed
of well-defined nests of small round blue cells, which were
separated by abundant desmoplastic stroma (Figure 2).
The spermatic cord and epididymis were also involved.
Immunohistochemical evaluation exhibited the following:
Cytokeratin Pan (+), Epithelial Membrane Antigen (+),
Cytokeratin 7(−), vimentin (+), desmin (+) (Figure 3),
Inhibin (−/+), Chromogranin A (weakly +), synaptophysinLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Computed tomography showed multiple lesions in left
inguinal region, and near-bilateral iliac vessels, suggestive of
multiple metastases. Figure 3 Desmin was positive for immunohistochemistry.
Magnification × 200
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Tumor-1 (WT-1) protein (−), Myogenin (−/+), MyoD1 (−)
and Neuron-specific enolase (+). Molecular evidence of
t(11;22) (p13;q12) was detected by fluorescent in situ
hybridization (FISH). Based on the abovementioned
evidence, a diagnosis of testicular DSRCT was confirmed
(pT3 N2 M1 S0).
The patient was discharged on the fifth postoperative
day in a good condition. In the third postoperative week,
he was readmitted to the Department of Oncology at
our hospital and received the VAC multi-agent systemic
chemotherapy regimen consisting of vincristine (2 mg,
day 1), adriamycin (75 mg/m2, day 1) and cyclophospha-
mide (1.2 g/m2, day 1). After six cycles of chemotherapy,
the patient was appraised as being in partial remission.
Postoperative 9-month follow-up indicated no progres-
sion as measured by CT assessment (Figure 4).Figure 2 Well-defined nests of small round blue cells separated
by abundant desmoplastic stroma (hematoxylin and eosin stain;
magnification × 100).Discussion
To our knowledge, this is the first case with testicular
DSRCT documented in the literature. DSRCT has a male
predominance and occurs most frequently in the second
to third decades of life [3]. As it can have delitescent onset
without apparent symptoms and is highly aggressive,
DSRCT is often diagnosed at a relatively advanced stage.
Furthermore, owing to the paucity of this tumor, there is
no optimal treatment strategy and favorable long-term
survival have not been achieved.
The diagnosis of DSRCT remains challenging. Because
most DSRCTs are found in the abdominal cavity, some
non-specific gastrointestinal symptoms (such as nausea,
vomiting, abdominal distension and pain) and a palpable
abdominal mass, are the main problems leading to patients
visiting a doctor. If present in extraperitoneal sites, DSRCT
can cause specific symptoms, mostly owing to expansion
and compression of the tumor. Weight loss, acratia, ascites,
and cachexia may occur when there is tumor disseminationFigure 4 Computed tomography showed shrunken lesions in
left inguinal region, and near-bilateral iliac vessels in the ninth
postoperative month.
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In our case, the patient was in good general condition
when he visited his doctor, but multiple metastases had
already developed. The tumor features, such as non-
specific manifestations and high aggression, meant that
the patient was already experiencing late-stage disease
at his first visit.
Imaging methods can help to detect DSRCT, although
there are no typical characteristics. CT scans show
homogenous low attenuation with modest uniform
enhancement on contrast-enhanced CT in small masses,
while central low attenuation with modest heterogeneous
enhancement on post-contrast CT, suggestive of central
hemorrhage or necrosis, may be observed in cases of
larger masses [12]. In addition, calcification is relatively
common. Ultrasonography and magnetic resonance
imaging also reveal one or multiple nodules ‘studding‘
the peritoneal cavity or other locations [13]. Positron
emission tomography (PET)/CT is recommended as an
effective evaluation of tumor staging [14]. In a retro-
spective study, Arora et al. evaluated the role of fluoro-
deoxyglucose PET/CT for diagnosis of DSRCT, and
found an accurate detection of 97.4% of all DSRCTs,
with sensitivity, specificity, positive predictive value, and
negative predictive value of 96.1%, 98.6%, 98.0%, and
97.1%, respectively [12]. Recently, fine-needle aspiration
cytology has been tried, and found to provide another
effective approach for early diagnosis and chemothera-
peutic response assessment of DSRCT [15].
Microscopically, DSRCT consists of well-defined nests
of small round blue cells with hyperchromatic nuclei
and indistinct nucleoli, which are separated by affluent
desmoplastic stroma. Peripheral palisading of tumor cells
and rosette-like structures may be observed [1,16]. Immu-
nohistochemistry demonstrates divergent differentiation
of DSRCT, which can be used as a definite diagnostic
marker for DSRCT. The tumor stains positivelhy for sev-
eral epithelial (e.g. keratin), mesenchymal (e.g. vimentin),
myogenic (e.g. desmin), and neural (e.g. CD56) markers,
thus desmin and vimentin together produce a unique
staining pattern, namely the punctuate and perinuclear
cytoplasmic positivity, which is a notable trait of DSRCT
[16]. C19, an antibody to the C-terminal region of the
WT1 protein, has been proven useful for differentiating
DSRCT from Ewing sarcoma/primitive neuroectodermal
tumor (EWS/PNET) when genetic information is unavail-
able [17]. The presence of the specific cytogenetic abnor-
mality t(11;22)(p13;q12) is observed in more than 90% of
all patients [18], which eventually promotes uncontrolled
proliferation of DSRCT cells [19]. Several staging systems
have been suggested for classification of peritoneal malig-
nancies [20], but no validated staging system has been
proposed for DSRCT. Recently, a new staging system
based on the Peritoneal Cancer Index was proposed, bywhich comparison of DSRCT outcomes may be applied,
although this was carried out with only a small cohort of
patients and needs further validation [21]. In our case, we
used the staging system established by UICC [22] in 2002
for testicular tumor, because no other available staging
systems were suitable for this rare case.
In general, DSRCT must be distinguished from other
small round cell tumors, such as EWS/PNET, neuro-
blastoma, and lymphoma. Similarly to DSRCT, EWS/PNET
is also composed of small round cells in sheets or nests.
Typically, EWS/PNET is positive for CD99 and vimentin,
and negative for cytokeratins and myogenic markers.
Different from DSRCT, which has a translocation of t
(11;22)(p13;q12), EWS/PNET has a characteristic recip-
rocal chromosomal translocation of t(11;22)(q24;q12) [16].
Neuroblastoma often occurs in children. Tumor cells are
negative for CK, WT1 and desmin, and the stroma is rich
in nerve fiber network, with ganglion cell differentiation
commonly observed [23]. High-grade lymphoma may
share similar histologic features with DSRCT, however,
lymphomas often display a diffuse growth pattern. Positive
lymphoid markers and negative epithelial and myogenic
markers can help with the differential diagnosis [24].
Currently, no consensus has been made as to the
treatment protocols for DSRCT [25]. Debulking surgery,
radiotherapy, and chemotherapy are possible therapeutic
strategies, although none of them appears to have better
efficacy than the others. Debulking surgery is still the main
approach of DSRCT management. In a retrospective
study, a 3-year survival rate of 58% was reported for
patients who received debulking surgery, whereas no
patients in the non-surgical group survived for more than
3 years [26]. Although DSRCT is somewhat sensitive
to chemotherapy and radiotherapy, durable remissions
remain rare [27]. Chemotherapeutic agents commonly
administrated for DSRCT include doxorubicin, cyclophos-
phamide, vincristine, ifosfamide and etoposide. Hyperther-
mic intraperitoneal chemotherapy (HIPEC) has been
performed in some institutions [28,29], and the 3-year
survival in patients receiving debulking surgery with
HIPEC was 71%, compared with 62% in patients who
underwent surgery alone; however this did not reach statis-
tical significance [17]. Radiotherapy is helpful in prolonging
life but does not promote long-term survival [1].
Generally speaking, the prognosis of DSRCT is poor. A
median progression-free survival of 2.6 years was reported
by Schwarz et al., and another study group reported that
71% of patients died within a mean of 25.2 months [30,31].
Because no standard therapeutic strategy has been recom-
mended, we administrated the VAC protocol to our patient
after debulking surgery, following the treatment for
sarcoma, and there was no progression appeared at the
postoperative 9-month follow-up. However, the patient
requires further observation due to the follow-up time.
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DSRCT is a relatively uncommon and highly aggressive
tumor, with poor prognosis. The diagnosis is usually
established by immunohistochemistry. To date, no standard
treatment protocol has been proposed. More investigations
are warranted to define the optimal therapeutic strategy.
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